This session will be led by Douglas Kalman PhD, Alan Feldstein Esq., and Rick Collins, Esq. The session will define and discuss the emerging areas of science and consumer-based healthcare known as Personalized Medicine, Genomics and NutriGenomics. More specifically, the Roundtable will elaborate on what Nutrigeomics and Genomics in general can tell us and what boundaries exists for any companies who are thinking of expanding into this area of interest. Discussion of the recent FDA vs. 23andMe action as well as NIH Office of Genomics guidance will be covered. In addition real world examples of what DNA and related testing for the home consumer will be highlighted. Come learn about this fast emerging hot topic!